ACCP "Excellence in Achievement" 

The ACCP "Excellence in Achievement" Program serves to acknowledge ACCP Members whose engagement with ACCP events/committees and contributions to the organization are deserving of recognition.

The ACCP “Excellence in Achievement” Program is pleased to recognize Ravi Shankar Prasad Singh, PhD, Senior Director of Clinical Pharmacology, Early Clinical Development at Pfizer Inc. Dr. Singh joined ACCP as a Student Member in 2014, became a Member in 2016 and a ACCP Fellow in 2022. He has participated in the Publications, Membership and Education Committees and is currently a member of the Honors & Awards Committee. Dr. Singh was a Student Abstract Award Winner in 2014, a Faculty Speaker at the 2019 ACCP Annual Meeting and an Abstract Reviewer for the 2020 Annual Meeting. We appreciate his contributions to the society.

Dr. Singh received his PhD from the Univ of Saskatchewan, College of Pharmacy & Nutrition. He began his career as a Junior Scientist, Drug Metabolism & Pharmacokinetics at Dr. Reddy's Laboratory in Hyderabad, India. After completing his PhD, Dr. Singh joined the Dept of Pharmaceutics at the Univ of Florida as a Post-doctoral Associate under the mentorship of the late Dr. Hartmut Derendorf. He then moved to Illinois to join AbbVie Inc as Senior Clinical Pharmacokineticist in Clinical Pharmacology & Pharmacometrics. Currently, Dr. Singh is a Senior Director of Clinical Pharmacology, Early Clinical Development at Pfizer Inc. Throughout his work history, mentorship has been an important element of his work. Dr. Singh has mentored a Post-doctoral fellow and co-mentored PhD graduate students, exchange students, PharmD students and scientists. Additionally, he has published extensively and has won numerous awards, most recently the Pfizer Worldwide Research, Development and Medical Individual Achievement Award for PAXLOVID Development in 2022.

Dr. Singh shared his thoughts on what ACCP membership means to him:

“Since I joined ACCP as a Post-doctoral Fellow in 2011, it provided me several opportunities to get involved in various committees and work with the leaders of the clinical pharmacology field. Being a very close-knit scientific community, ACCP provided a great opportunity to network and collaborate which helped in my professional growth. Among the many admirable features of ACCP, the key ones for me are its inclusivity, propensity to nurture talents and focus on educating professionals as well as community with the cutting-edge science. ACCP has highly enthusiastic and committed Members, Leaders and Staff who are fun to work with. Contributing to ACCP has been a very fulfilling experience and I will continue to do so in the future.”

Congratulations, Dr. Singh, on being recognized for your outstanding achievements and contributions to ACCP!